Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-24

Clinical Trial Update: INVESTIGATION OF THE ANTI-NEOPLASTIC EFFECT OF TRISHUL (AYURVEDIC AGENT) ON TUMOUR REGRESSION OF RECTAL CANCER- A PILOT STUDY [Phase 2]

View source ↗

Summary

A Phase 2 pilot clinical trial is investigating the anti-tumor effects of the Ayurvedic agent Trishul on rectal cancer, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trishul

Snippet

Sponsor: University of Kelaniya | Conditions: Efficacy of Trishul | Phase 2 | Status: NOT_YET_RECRUITING